Variant report
Variant | nsv967699 |
---|---|
Chromosome Location | chr4:171766688-171772927 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs565352775 | chr4:171766707-171766708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs557225741 | chr4:171766729-171766730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs541595950 | chr4:171766740-171766741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs189444351 | chr4:171766752-171766753 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs530274828 | chr4:171766770-171766771 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs182237622 | chr4:171766785-171766786 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs570287420 | chr4:171766801-171766802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7669155 | chr4:171766823-171766824 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
9 | rs372116996 | chr4:171766828-171766829 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550982327 | chr4:171766840-171766841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570974185 | chr4:171766845-171766846 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs376118108 | chr4:171766895-171766896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs141559890 | chr4:171766918-171766919 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147025635 | chr4:171766944-171766945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs7669543 | chr4:171766985-171766986 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs575056479 | chr4:171770974-171770975 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs539467500 | chr4:171770991-171770992 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552956104 | chr4:171771003-171771004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs553077073 | chr4:171771053-171771054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs183712753 | chr4:171771063-171771064 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs567378791 | chr4:171771119-171771120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs572911329 | chr4:171771127-171771128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs572816443 | chr4:171771131-171771132 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541622041 | chr4:171771132-171771133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs368974330 | chr4:171771136-171771137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs561925210 | chr4:171771153-171771154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575399115 | chr4:171771156-171771157 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs544094093 | chr4:171771210-171771211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs80014058 | chr4:171771211-171771212 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs564071787 | chr4:171771290-171771291 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs34262189 | chr4:171771372-171771373 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7439560 | chr4:171771401-171771402 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs75845094 | chr4:171771453-171771454 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs372706341 | chr4:171771489-171771490 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs7671556 | chr4:171771496-171771497 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs140411924 | chr4:171771507-171771508 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189318436 | chr4:171771641-171771642 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs569430702 | chr4:171771669-171771670 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs150370740 | chr4:171771693-171771694 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs117829749 | chr4:171771721-171771722 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs28514450 | chr4:171771761-171771762 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs145066189 | chr4:171771792-171771793 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs552944686 | chr4:171771841-171771842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs566399209 | chr4:171771865-171771866 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535534312 | chr4:171771871-171771872 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs62344266 | chr4:171771884-171771885 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs575383362 | chr4:171771953-171771954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs544027023 | chr4:171772055-171772056 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs557600205 | chr4:171772090-171772091 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs182262325 | chr4:171772095-171772096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Developmental delay | 22127048 | CNVD |
Schizophrenia | 23813976 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:171766200-171767000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr4:171770800-171771200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr4:171771000-171771400 | Enhancers | HMEC | breast |
4 | chr4:171771000-171771800 | Enhancers | GM12878-XiMat | blood |
5 | chr4:171771200-171774800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |